HUTCHMED (China) Limited

Direct answer

HUTCHMED (China) Limited is publicly traded on LSE under the ticker HCM.L.

HUTCHMED (China) Limited is a biopharmaceutical company engaged in the research, development, and commercialization of innovative targeted therapies and immunotherapies. Its focus lies in treating cancer and immunological disorders, serving patients both in Hong Kong and globally. The company's operations are divided into Oncology/Immunology and Other Ventures. Among its key assets is Savolitinib, an inhibitor...

Can you invest in HUTCHMED (China) Limited?

Yes. HUTCHMED (China) Limited is publicly traded on LSE under the ticker HCM.L.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for HUTCHMED (China) Limited

Detailed equity research is provided by MarketSnap.